Skip to main content


Latest articles

14-07-2017 | Oncology | Main feed | News

Tivozanib, ribociclib EMA authorizations extend oncology armamentarium

Click here for details on these decisions

19-06-2017 | Oncology | Conference report | News

Lenvatinib equals sorafenib for unresectable HCC OS

REFLECT study findings indicate that lenvatinib offers non-inferior overall survival compared with the current standard of care, sorafenib, for the first-line treatment of patients with unresectable hepatocellular carcinoma.

03-05-2017 | Oncology | News | Article

Regorafenib approved for liver cancer, midostaurin for AML

Click through for the details of these decisions

28-09-2016 | Oncology | News | Article

MRI outplays ultrasonography in HCC detection

Screening cirrhotic patients at high risk of hepatocellular carcinoma with gadoxetic acid-enhanced magnetic resonance imaging results in significantly improved HCC detection compared with ultrasonography, findings indicate.

21-04-2013 | Metabolism | Article

Orlistat liver injury link questioned

Researchers have found that users of the obesity drug, orlistat, have an increased risk for acute liver injury compared with non-users in the time period prior to taking the drug.

15-04-2013 | Gynaecology | Article

Phototherapy plus reflecting curtains effective for neonatal jaundice

Neonatal hyperbilirubinemia requiring intensive phototherapy can be treated equally well with single phototherapy using reflecting curtains as with double phototherapy, the results of a study indicate.

14-04-2013 | Metabolism | Article

HCV infection alone not linked to diabetes risk

Individuals with hepatitis C virus infection are at increased risk for developing Type 2 diabetes only if they have elevated alanine aminotransferase levels, show study findings published in the American Journal of Gastroenterology.

07-04-2013 | Gastroenterology | Article

HCV-infected patients bury heads in sand

Researchers have found poor levels of knowledge about hepatitis C virus among individuals with HCV mono-infection and HCV/HIV co-infection.

24-03-2013 | Legal medicine | Article

Greater attention to hepatitis C virus in detention facilities needed

Around 2.2 million prison detainees worldwide are anti-hepatitis C virus positive, estimate the authors of a global meta-analysis, who say that more must be done to identify and treat HCV in this population.

17-03-2013 | Psychology | Article

HIV infection speeds up HCV liver damage

Researchers have found that co-infection with HIV accelerates hepatitis C virus-related liver damage by nearly 10 years.

10-03-2013 | Genetics | Article

Resistant HBV mutants raise public health concerns

Researchers have shown that treatment with anti-hepatitis B virus nucleoside analogs in HBV–HIV co-infection results in a substantial increase in mutants linked to treatment and vaccine resistance.

03-03-2013 | Surgery | Article

Liver stem cell therapy ‘on its way’

Researchers have successfully grown liver stem cells in culture for the first time and transplanted them into a mouse model.

24-02-2013 | Gastroenterology | Article

Antioxidant boosts liver transplant outcomes

Infusion of N-acetylcysteine in liver donors can significantly improve the outcome of transplantation, research shows.

17-02-2013 | Gastroenterology | Article

Early PBC prognosis advocated

Biochemical response to ursodeoxycholic acid at 6 months is a better predictor for primary biliary cirrhosis prognosis than the current standard of 1 year, study results suggest.

10-02-2013 | Gastroenterology | Article

Biomarkers could be antidote to overdose overtreatment

Researchers have identified several biomarkers that can accurately predict acute liver injury after acetaminophen overdose.

10-02-2013 | Gastroenterology | Article

MRI promising for noninvasive hepatic steatosis assessment

Magnetic resonance imaging allows accurate measurement of the extent and severity of hepatic steatosis in patients with nonalcoholic fatty liver disease, demonstrate the results of two studies published in



03-02-2013 | Gastroenterology | Article

Interferon retreatment warning in HCV

Hepatitis C virus patients who do not respond to interferon should not receive further treatment with the drug, say the authors of a new



31-01-2013 | Psychology | Article

Epidemiology model supports 20:80 transmission rule in HCV

A new hepatitis C virus transmission model combining genetic and epidemiologic data reveals that the majority of transmission of the virus is by a minority of intravenous drug users.

27-01-2013 | Gastroenterology | Article

Shorter surveillance intervals detect HCC earlier

Hepatocellular carcinoma surveillance in at-risk patients at intervals of less than 6 months picks up smaller tumors compared with longer intervals, show two recently published studies.

20-01-2013 | Psychology | Article

Tattooing poses HCV risk

Hepatitis C virus infection is more common in people who have had a tattoo, research shows.

Image Credits